{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T01:30:59Z","timestamp":1769304659587,"version":"3.49.0"},"reference-count":46,"publisher":"Emerald","issue":"4","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.emerald.com\/insight\/site-policies"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["LHT"],"published-print":{"date-parts":[[2020,4,24]]},"abstract":"Purpose<\/jats:title>Drug repurposing involves the identification of new applications for existing drugs. Owing to the enormous rise in the costs of pharmaceutical R&D, several pharmaceutical companies are leveraging repurposing strategies. Parkinson's disease is the second most common neurodegenerative disorder worldwide, affecting approximately 1\u20132 percent of the human population older than 65 years. This study proposes a literature-based drug repurposing strategy in Parkinson's disease.<\/jats:p><\/jats:sec>Design\/methodology\/approach<\/jats:title>The literature-based drug repurposing strategy proposed herein combined natural language processing, network science and machine learning methods for analyzing unstructured text data and producing actional knowledge for drug repurposing. The approach comprised multiple computational components, including the extraction of biomedical entities and their relationships, knowledge graph construction, knowledge representation learning and machine learning-based prediction.<\/jats:p><\/jats:sec>Findings<\/jats:title>The proposed strategy was used to mine information pertaining to the mechanisms of disease treatment from known treatment relationships and predict drugs for repurposing against Parkinson's disease. The F1 score of the best-performing method was 0.97, indicating the effectiveness of the proposed approach. The study also presents experimental results obtained by combining the different components of the strategy.<\/jats:p><\/jats:sec>Originality\/value<\/jats:title>The drug repurposing strategy proposed herein for Parkinson's disease is distinct from those existing in the literature in that the drug repurposing pipeline includes components of natural language processing, knowledge representation and machine learning for analyzing the scientific literature. The results of the study provide important and valuable information to researchers studying different aspects of Parkinson's disease.<\/jats:p><\/jats:sec>","DOI":"10.1108\/lht-08-2019-0170","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T13:48:37Z","timestamp":1588168117000},"page":"741-750","source":"Crossref","is-referenced-by-count":24,"title":["Drug repurposing against Parkinson's disease by text mining the scientific literature"],"prefix":"10.1108","volume":"38","author":[{"given":"Yongjun","family":"Zhu","sequence":"first","affiliation":[]},{"given":"Woojin","family":"Jung","sequence":"additional","affiliation":[]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Chao","family":"Che","sequence":"additional","affiliation":[]}],"member":"140","reference":[{"key":"key2020110406481491800_ref044","first-page":"865","article-title":"Can literature analysis identify innovation drivers in drug discovery?","volume":"8","year":"2009","journal-title":"Analysis"},{"key":"key2020110406481491800_ref001","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","year":"2004","journal-title":"Nature Reviews Drug Discovery"},{"key":"key2020110406481491800_ref045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/bib\/bbr005","article-title":"Literature mining, ontologies and information visualization for drug repurposing","volume":"12","year":"2011","journal-title":"Briefings In Bioinformatics"},{"key":"key2020110406481491800_ref002","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.drudis.2018.01.018","article-title":"A bibliometric review of drug repurposing","volume":"23","year":"2018","journal-title":"Drug Discovery Today"},{"key":"key2020110406481491800_ref003","article-title":"Translating embeddings for modeling multi-relational data","year":"2013"},{"key":"key2020110406481491800_ref004","first-page":"1851","article-title":"Combining human disease genetics and mouse model phenotypes towards drug repositioning for Parkinson's disease","volume":"2015","year":"2015","journal-title":"AMIA Annual Symposium Proceedings"},{"key":"key2020110406481491800_ref005","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nrd3869","article-title":"Drug repositioning for Alzheimer's disease","volume":"11","year":"2012","journal-title":"Nature Reviews Drug Discovery"},{"key":"key2020110406481491800_ref006","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/ph6101304","article-title":"Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease","volume":"6","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"key2020110406481491800_ref007","first-page":"323","article-title":"Drug repurposing and adverse event prediction using high-throughput literature analysis","volume":"3","year":"2011","journal-title":"Wiley Interdisciplinary Reviews: Systems Biology and Medicine"},{"key":"key2020110406481491800_ref008","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.1592\/phco.30.pt2.51S","article-title":"Drug repurposing for drug development in stroke","volume":"30","year":"2010","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"key":"key2020110406481491800_ref009","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000362419","article-title":"Advances in drug development for Parkinson's disease: present status","volume":"93","year":"2014","journal-title":"Pharmacology"},{"key":"key2020110406481491800_ref010","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.0b013e31824e8f0d","article-title":"Amantadine: the journey from fighting flu to treating Parkinson disease","volume":"78","year":"2012","journal-title":"Neurology"},{"key":"key2020110406481491800_ref011","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2018.04.023","article-title":"Old wines in new bottles: repurposing opportunities for Parkinson's disease","volume":"830","year":"2018","journal-title":"European Journal of Pharmacology"},{"key":"key2020110406481491800_ref012","first-page":"29","article-title":"Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease","volume":"5","year":"2016","journal-title":"American Journal of Neurodegenerative Diseases"},{"key":"key2020110406481491800_ref013","article-title":"Drug repurposing is a new opportunity for developing drugs against neuropsychiatric disorders","volume":"2016","year":"2016","journal-title":"Schizophrenia Research and Treatment"},{"key":"key2020110406481491800_ref046","first-page":"104","article-title":"Literature analysis for systematic drug repurposing: a case study from Biovista","volume":"8","year":"2011","journal-title":"Drug Discovery Today: Therapeutic Strategies"},{"key":"key2020110406481491800_ref014","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/bib\/bbv020","article-title":"A survey of current trends in computational drug repositioning","volume":"17","year":"2016","journal-title":"Briefings in Bioinformatics"},{"key":"key2020110406481491800_ref015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.drudis.2012.08.005","article-title":"In silico drug repositioning: what we need to know","volume":"18","year":"2013","journal-title":"Drug Discovery Today"},{"key":"key2020110406481491800_ref016","first-page":"878","article-title":"A review of network-based approaches to drug repositioning","volume":"19","year":"2017","journal-title":"Briefings in Bioinformatics"},{"key":"key2020110406481491800_ref017","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nrd884","article-title":"Value of novelty?","volume":"1","year":"2002","journal-title":"Nature Reviews Drug Discovery"},{"key":"key2020110406481491800_ref018","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.tim.2018.04.004","article-title":"Drug repurposing for viral infectious diseases: how far are we","volume":"26","year":"2018","journal-title":"Trends in Microbiology"},{"key":"key2020110406481491800_ref019","article-title":"Drug repositioning: a machine-learning approach through data integration","volume":"5","year":"2013","journal-title":"Journal of Cheminformatics"},{"key":"key2020110406481491800_ref020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tips.2013.03.004","article-title":"Challenges and opportunities of drug repositioning","volume":"34","year":"2013","journal-title":"Trends in Pharmacological Sciences"},{"key":"key2020110406481491800_ref021","article-title":"Computational drug repositioning based on side-effects mined from social media","volume":"2","year":"2016","journal-title":"PeerJ Computer Science"},{"key":"key2020110406481491800_ref022","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0022-3859.81870","article-title":"Drug repositioning: re-investigating existing drugs for new therapeutic indications","volume":"57","year":"2011","journal-title":"Journal of Postgraduate Medicine"},{"key":"key2020110406481491800_ref023","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuropharm.2018.08.027","article-title":"CNS repurposing - potential new uses for old drugs: examples of screens for Alzheimer's disease, Parkinson's disease and spasticity","volume":"147","year":"2019","journal-title":"Neuropharmacology"},{"key":"key2020110406481491800_ref024","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbrc.2014.12.101","article-title":"A bidirectional drug repositioning approach for Parkinson's disease through network-based inference","volume":"457","year":"2015","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"key2020110406481491800_ref025","article-title":"Using social media data to identify potential candidates for drug repurposing: a feasibility study","volume":"5","year":"2016","journal-title":"JMIR research protocols"},{"key":"key2020110406481491800_ref026","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.disamonth.2007.05.002","article-title":"Current pharmacotherapeutic treatment options in Parkinson's disease","volume":"53","year":"2007","journal-title":"Disease-a-Month"},{"key":"key2020110406481491800_ref027","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jbi.2003.11.003","article-title":"The interaction of domain knowledge and linguistic structure in natural language processing: interpreting hypernymic propositions in biomedical text","volume":"36","year":"2003","journal-title":"Journal of Biomedical Informatics"},{"key":"key2020110406481491800_ref028","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/bib\/bbr021","article-title":"Drug repositioning for orphan diseases","volume":"12","year":"2011","journal-title":"Briefings in Bioinformatics"},{"key":"key2020110406481491800_ref029","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/bib\/bbv048","article-title":"Bioinformatics methods in drug repurposing for Alzheimer's disease","volume":"17","year":"2016","journal-title":"Briefings in Bioinformatics"},{"key":"key2020110406481491800_ref030","first-page":"15","article-title":"Drug discovery in Parkinson's disease-update and developments in the use of cellular models","volume":"2011","year":"2011","journal-title":"International Journal of High Throughput Screening"},{"key":"key2020110406481491800_ref031","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2017.07.013","article-title":"Drug repurposing in cancer","volume":"124","year":"2017","journal-title":"Pharmacological Research"},{"key":"key2020110406481491800_ref032","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/00207454.2014.986673","article-title":"Identification of potential drugs for Parkinson's disease based on a sub-pathway method","volume":"126","year":"2016","journal-title":"International Journal of Neuroscience"},{"key":"key2020110406481491800_ref033","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.drudis.2016.10.008","article-title":"Drug repurposing by integrated literature mining and drug-gene-disease triangulation","volume":"22","year":"2017","journal-title":"Drug Discovery Today"},{"key":"key2020110406481491800_ref034","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-4939-0709-0_14","article-title":"Systematic drug repurposing through text mining","volume":"1159","year":"2014","journal-title":"Methods in Molecular Biology"},{"key":"key2020110406481491800_ref035","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1089\/ars.2009.2697","article-title":"Parkinson's disease: from molecular pathways in disease to therapeutic approaches","volume":"11","year":"2009","journal-title":"Antioxidants and Redox Signaling"},{"key":"key2020110406481491800_ref036","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.tips.2016.01.007","article-title":"Repurposing drugs to target the diabetes epidemic","volume":"37","year":"2016","journal-title":"Trends in Pharmacological Sciences"},{"key":"key2020110406481491800_ref037","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1109\/TKDE.2017.2754499","article-title":"Knowledge graph embedding: a survey of approaches and applications","volume":"29","year":"2017","journal-title":"IEEE Transactions on Knowledge and Data Engineering"},{"key":"key2020110406481491800_ref038","article-title":"Knowledge graph embedding by translating on hyperplanes","year":"2014"},{"issue":"Suppl 5","key":"key2020110406481491800_ref039","article-title":"Computational drug repositioning through heterogeneous network clustering","volume":"7","year":"2013","journal-title":"BMC Systems Biology"},{"key":"key2020110406481491800_ref040","article-title":"Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing","volume":"14","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"key2020110406481491800_ref041","first-page":"488","article-title":"Literature-based discovery of new candidates for drug repurposing","volume":"18","year":"2017","journal-title":"Briefings in Bioinformatics"},{"key":"key2020110406481491800_ref042","article-title":"Repositioning drugs by targeting network modules: a Parkinson's disease case study","volume":"18","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"key2020110406481491800_ref043","first-page":"683","article-title":"Metformin and cancer: an existing drug for cancer prevention and therapy","volume":"15","year":"2018","journal-title":"Oncology letters"}],"container-title":["Library Hi Tech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.emerald.com\/insight\/content\/doi\/10.1108\/LHT-08-2019-0170\/full\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.emerald.com\/insight\/content\/doi\/10.1108\/LHT-08-2019-0170\/full\/html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T22:14:58Z","timestamp":1753395298000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.emerald.com\/lht\/article\/38\/4\/741-750\/453229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,24]]}},"alternative-id":["10.1108\/LHT-08-2019-0170"],"URL":"https:\/\/doi.org\/10.1108\/lht-08-2019-0170","relation":{},"ISSN":["0737-8831"],"issn-type":[{"value":"0737-8831","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,24]]}}}